[An unusual case of olmesartan induced enteropathy].

Ann Pathol

Service d'anatomie pathologique, cliniques universitaires Saint-Luc, Tour Franklin -1, 10, avenue Hippocrate, 1200 Bruxelles, Belgique.

Published: June 2019

Olmesartan induced enteropathy was first described in 2012. It is a rare adverse effect of this antihypertensive drug. The clinical presentation commonly includes severe chronic diarrhea leading to weight loss and a variable degree of dehydration. Histological findings are most commonly observed in the duodenum and consist of partial or total villous atrophy, increased intraepithelial lymphocytes and inflammation in the lamina propria. Involvement of gastric and colic mucosa has also been described. We report on the case of a 63-year-old man, treated by olmesartan, who presented with severe chronic diarrhea. Biopsies from different levels of the gastrointestinal tract revealed a pandigestive intraepithelial lymphocytosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2018.10.007DOI Listing

Publication Analysis

Top Keywords

olmesartan induced
8
severe chronic
8
chronic diarrhea
8
[an unusual
4
unusual case
4
case olmesartan
4
induced enteropathy]
4
enteropathy] olmesartan
4
induced enteropathy
4
enteropathy described
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!